Shares of Himax Technologies plunged 6.4% to $17.10 on June 10, extending a brutal slide that has erased nearly 29% of the stock's value since June 3. A sell signal was issued from a pivot top on June 3, and the stock has fallen over 24% since. The catalyst: an analyst report flagging potential delays in Himax's optical technology pipeline, landing at exactly the wrong moment — during the worst week for chip stocks in years.
A $1.3 Trillion Chip Selloff Left No One Standing. Broadcom's modest miss on AI chip guidance on June 5 erased over $1.3 trillion in market value from the global semiconductor sector in a single session.
The iShares Semiconductor ETF sank about 10%, one of its worst sessions in years. For a $3 billion company like Himax, which trades on sentiment toward next-generation chip plays, this kind of sector-wide repricing hits disproportionately hard. Investors rotating out of speculative names punish smaller stocks first and ask questions later.
Optical Technologies Are the Growth Bet — And It Just Got Questioned. Himax has been banking heavily on two optical businesses: tiny lenses used in high-speed data-center connections (called co-packaged optics), and microdisplays for augmented-reality smart glasses. The company's own goal for 2026 is to achieve mass-production readiness for these products, with only limited shipments expected this year and an accelerating ramp starting in 2027. Any hint of delay pushes meaningful revenue further into the future — a problem when the stock trades at a trailing price-to-earnings ratio of roughly 105x on just $32 million in trailing net income. At that valuation, the timeline is the thesis.
The Core Business Is Shrinking, Not Growing. Q1 2026 revenue fell 7.5% year-over-year to $199 million, and net income dropped 60% to $8 million.
CEO Jordan Wu acknowledged that surging AI demand is straining foundry capacity for the mature chip processes Himax relies on, pushing up costs. Management guided Q2 revenue up 10–13% sequentially, but that rebound hasn't insulated the stock from broader fear.
The Bull Case Now Rests on 2027 and Beyond. Management expects "upward momentum through the remainder of 2026" from new automotive projects entering production in the second half.
But analysts note the long-term upside from optics "remains unproven." With $287.6 million in cash and modest debt, Himax isn't in financial danger — but shareholders are paying a triple-digit earnings multiple for a turnaround that just got harder to time.